JP2686172B2 - Amide derivative and external preparation for skin containing the same - Google Patents
Amide derivative and external preparation for skin containing the sameInfo
- Publication number
- JP2686172B2 JP2686172B2 JP24684790A JP24684790A JP2686172B2 JP 2686172 B2 JP2686172 B2 JP 2686172B2 JP 24684790 A JP24684790 A JP 24684790A JP 24684790 A JP24684790 A JP 24684790A JP 2686172 B2 JP2686172 B2 JP 2686172B2
- Authority
- JP
- Japan
- Prior art keywords
- amide derivative
- skin
- external preparation
- mol
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、新規なアミド誘導体、及びそれを含有する
皮膚外用剤、特に、角層のバリアー機能を本質的に改善
(正常なバリアー機能の維持、障害を受けたバリアー機
能の回復)し得る皮膚外用剤に関する。The present invention relates to a novel amide derivative, and a skin external preparation containing the same, and in particular, the barrier function of the stratum corneum is essentially improved (of normal barrier function). The present invention relates to a skin external preparation capable of maintaining and recovering a damaged barrier function).
角層は、皮膚の最表面にあって、体表面全体を覆い、
体外からの刺激や異物の侵入を防ぎ、また体内からの水
分の蒸散を防ぐ等の役割を果たしている。The stratum corneum is on the outermost surface of the skin and covers the entire body surface,
It plays a role in preventing irritation from outside the body and invasion of foreign matter, and also preventing evaporation of water from the body.
しかし、何らかの原因によって角層のバリアー機能が
弱まると、皮膚に炎症が起きやすくなったり、肌あれが
生じ易くなるなどの問題が起こる。However, if the barrier function of the stratum corneum is weakened for some reason, problems such as easy inflammation of the skin and easy occurrence of rough skin occur.
また、アラキドン酸やリノール酸などの必須脂肪酸を
含まない食物を摂取し続けるなどして体内で必須脂肪酸
が不足もしくは欠乏し、必須脂肪酸欠乏症になると、角
層のバリアー機能に障害が生じることが知られている。It is also known that when essential fatty acids are deficient or deficient in the body by continuing to eat foods that do not contain essential fatty acids such as arachidonic acid and linoleic acid, and essential fatty acid deficiency occurs, the barrier function of the stratum corneum is impaired. Has been.
そして、上記角層のバリアー機能の維持には、角層細
胞間の脂質、特にO−アシルセラミドが極めて重要な働
きを示すことが、脂肪間の脂質の分析等の結果から明ら
かとなっている。Then, it has been clarified from the results of the analysis of lipids between fats that lipids between corneal cells, particularly O-acylceramide, play an extremely important role in maintaining the barrier function of the stratum corneum. .
また、皮脂線から分泌される脂質が皮表で皮脂膜を形
成することにより、角層のバリアー機能の一部が補われ
るとされており、従来、ワセリン等を配合した皮膚外用
剤等が、皮膚表面に被膜を形成させて角層のバリアー機
能を補充する目的で使用されている。Further, it is said that a part of the barrier function of the stratum corneum is supplemented by forming a sebaceous membrane on the skin surface with lipids secreted from the sebaceous line, and conventional skin external preparations containing vaseline etc. It is used for the purpose of forming a film on the skin surface to supplement the barrier function of the stratum corneum.
しかしながら、従来の皮膚外用剤等は、あくまでも一
時的に皮膚表面に被膜を形成させてバリアー機能を補充
しているにすぎず、本質的に角層のバリアー機能を改善
させるものではなかった。However, conventional external preparations for skin and the like merely form a film on the skin surface temporarily to replenish the barrier function, and do not essentially improve the barrier function of the stratum corneum.
従って、本発明の目的は、角層の正常なバリアー機能
を維持することができ、また障害を受けたバリアー機能
を回復することのできる皮膚外用剤、即ち、角層のバリ
アー機能を本質的に改善でき、炎症や肌あれ等を起こし
難くする皮膚外用剤を提供することにある。Therefore, the object of the present invention is to maintain the normal barrier function of the stratum corneum and to restore the damaged barrier function, that is, the external barrier agent of the stratum corneum. It is intended to provide an external preparation for the skin which can be improved and which makes it less likely to cause inflammation, rough skin and the like.
本発明者らは、上記目的を達成すべく鋭意研究した結
果、下記一般式(I)で表される新規アミド誘導体を含
有する皮膚外用剤が角層のバリアー機能を本質的に改善
できることを見出し、本発明を完成した。As a result of earnest studies to achieve the above-mentioned object, the present inventors have found that an external preparation for skin containing a novel amide derivative represented by the following general formula (I) can essentially improve the barrier function of the stratum corneum. The present invention has been completed.
(式中、R1は炭素数10〜40の直鎖若しくは分岐鎖の飽和
若しくは不飽和の炭化水素基を示し、R2は炭素数3〜39
の直鎖若しくは分岐鎖の炭化水素基を示し、R3は水素原
子又は炭素数10〜40の直鎖若しくは分岐鎖の飽和若しく
は不飽和の炭化水素基若しくはアシル基を示す。) 即ち、本発明は、前記一般式(I)で表わされるアミ
ド誘導体及びそれを含有する皮膚外用剤を提供するもの
である。 (In the formula, R 1 represents a linear or branched saturated or unsaturated hydrocarbon group having 10 to 40 carbon atoms, and R 2 represents 3 to 39 carbon atoms.
Is a straight chain or branched chain hydrocarbon group, and R 3 is a hydrogen atom or a straight chain or branched chain saturated or unsaturated hydrocarbon group having 10 to 40 carbon atoms or an acyl group. That is, the present invention provides an amide derivative represented by the general formula (I) and a skin external preparation containing the amide derivative.
以下、まず本発明のアミド誘導体について説明する。 Hereinafter, the amide derivative of the present invention will be described first.
前記一般式(I)で表わされる本発明のアミド誘導体
は、その製造法は特に限定されるものではなく、例え
ば、次の(1)〜(3)の方法により製造することがで
きる。The production method of the amide derivative of the present invention represented by the general formula (I) is not particularly limited, and can be produced, for example, by the following methods (1) to (3).
(1)前記一般式(I)においてR3が水素原子であるア
ミド誘導体(I−A)の製造方法: 上記アミド誘導体(I−A)は、公知の方法〔例え
ば、特開昭63−216852号公報に記載の方法〕に準じて製
造することができる。即ち、次に示される反応式に従っ
てグリシジルエーテルとエタノールアミンから得られる
アミン誘導体(II)に対して、塩基触媒の存在下でヒド
ロキシ脂肪酸低級アルキルエステル(III−A)又はヒ
ドロキシ脂肪酸ラクトン(IV)を作用させ、生成する低
級アルコールを留去しつつ反応させることにより製造す
ることができる。(1) Method for producing amide derivative (IA) in which R 3 is a hydrogen atom in the general formula (I): The amide derivative (IA) is a known method [eg, JP-A-63-216852]. The method described in Japanese Patent Publication No. 1994-242242). That is, a hydroxy fatty acid lower alkyl ester (III-A) or hydroxy fatty acid lactone (IV) is added to an amine derivative (II) obtained from glycidyl ether and ethanolamine according to the reaction formula shown below in the presence of a base catalyst. It can be produced by causing the reaction to occur while distilling off the produced lower alcohol.
(式中、R1及びR2は前記一般式(I)における場合と同
じ意味を表わし、R4は炭素数1〜5のアルキル基を示
す。) (2)前記一般式(I)においてR3が炭素数10〜40の直
鎖若しくは分岐鎖の飽和若しくは不飽和の炭化水素基で
あるアミド誘導体(I−B)の製造方法: 上記アミド誘導体(I−B)は、次に示される反応式
に従って、ヒドロキシ脂肪酸(III)若しくはヒドロキ
シ脂肪酸エステル(III−A)とアルキルハライド
(V)若しくはスルホン酸アルキルエステル(V1)とを
塩基の存在下で反応させることによりエーテル化脂肪酸
エステル(III−B)を得、これと前記(1)の方法で
得られるアミン誘導体(II)とを塩基触媒存在下で作用
させ、生成するアルコールを留去しつつ反応させること
により、製造することができる。 (In the formula, R 1 and R 2 have the same meanings as in the case of the general formula (I), and R 4 represents an alkyl group having 1 to 5 carbon atoms.) (2) In the general formula (I), R 4 Method for producing amide derivative (IB) in which 3 is a linear or branched saturated or unsaturated hydrocarbon group having 10 to 40 carbon atoms: The above amide derivative (IB) is a reaction shown by the following. According to the formula, an etherified fatty acid ester (III-B) is obtained by reacting a hydroxy fatty acid (III) or hydroxy fatty acid ester (III-A) with an alkyl halide (V) or a sulfonic acid alkyl ester (V1) in the presence of a base. ) Is obtained, and this is reacted with the amine derivative (II) obtained by the above method (1) in the presence of a base catalyst, and the produced alcohol is reacted while distilling off.
(式中、R1、R2及びR4は前記(1)の反応式における場
合と同じ意味を表わし、R3は炭素数10〜40の直鎖若しく
は分岐鎖の飽和若しくは不飽和の炭化水素基を示し、R5
はメチル基、フェニル基又はp−トルイル基を示す。ま
た、XはC1、Br又はIを示す。) (3)前記一般式(I)においてR3が炭素数10〜40の直
鎖若しくは分岐鎖の飽和若しくは不飽和のアシル基であ
るアミド誘導体(I−C)の製造方法: 上記アミド誘導体(I−C)は、次に示される反応式
に従って、ヒドロキシ脂肪酸エステル(III−A)と脂
肪酸(VII)とを適当な脱水剤〔例えば、 及びP(C6H5)3〕の存在下に縮合させてアシル脂肪酸
エステル(III−C)とし、これと前記(1)の方法で
得られるアミン誘導体(II)とを塩基触媒存在下で作用
させ、生成するアルコールを留去しつつ反応させること
により、製造することができる。 (In the formula, R 1 , R 2 and R 4 have the same meanings as in the reaction formula (1), and R 3 is a straight or branched chain saturated or unsaturated hydrocarbon having 10 to 40 carbon atoms. Represents a group, R 5
Represents a methyl group, a phenyl group or a p-toluyl group. X represents C1, Br or I. (3) A method for producing an amide derivative (IC) in which R 3 in the general formula (I) is a linear or branched saturated or unsaturated acyl group having 10 to 40 carbon atoms: I-C) is prepared by reacting a hydroxy fatty acid ester (III-A) and a fatty acid (VII) with a suitable dehydrating agent [eg, according to the reaction formula shown below. And P (C 6 H 5 ) 3 ], to give an acyl fatty acid ester (III-C), which is condensed with an amine derivative (II) obtained by the method (1) in the presence of a base catalyst. It can be produced by reacting it while allowing it to act and distill off the produced alcohol.
(式中、R1、R2及びR4は前記(1)の反応式における場
合と同じ意味を表わし、R6は炭素数9〜39の直鎖若しく
は分岐鎖の飽和若しくは不飽和の炭化水素基を示す。) また、上記アミド誘導体(I−C)は、適当な保護基
を用いて次に示される反応式に従っても製造することが
できる。 (In the formula, R 1 , R 2 and R 4 have the same meaning as in the reaction formula of the above (1), and R 6 is a linear or branched saturated or unsaturated hydrocarbon having 9 to 39 carbon atoms. Further, the above amide derivative (IC) can also be produced according to the reaction formula shown below using an appropriate protecting group.
(式中、R1、R2、R4及びR6は、前記の反応式における場
合と同じ意味を表わし、R7は を示し、R8はアセチル基又はtert−ブチルジフェニルシ
リル基を示す。) 即ち、ヒドロキシ脂肪酸エステル(III−A)のヒド
ロキシ基をテトラヒドロピラニル基、エトキシエチル基
等のエーテル系保護基R7で保護した後、アミン誘導体
(II)と塩基触媒存在下で反応させ、アミド誘導体(I
X)とし、次いで、アミド誘導体(IX)の2つのヒドロ
キシ基をアセチル基又はtert−ブチルジフェニルシリル
基(R8)で保護した後、保護基R7を、酸触媒存在下にア
ルコールを作用させて脱保護して、アミド誘導体(XI)
とし、次いで、適当な脱水剤〔例えば、 及びP(C6H5)3〕の存在下に脂肪酸(VII)を作用させ
るか、又は塩基の存在下に脂肪酸クロリド(XII)を作
用させて、アミド誘導体(XIII)とし、最後に、保護基
R8を脱保護〔R8がアセチル基の場合、低級アルコール中
K2CO3、Na2CO3等の塩基を用い、また、R8がtert−ブチ
ルジフェニルシリル基の場合、フッ化テトラブチルアン
モニウム等のフッ素イオンを用いる〕して、アミド誘導
体(I−C)を得る。 (In the formula, R 1 , R 2 , R 4 and R 6 have the same meanings as in the above reaction formula, and R 7 is And R 8 represents an acetyl group or a tert-butyldiphenylsilyl group. ) That is, after protecting the hydroxy group of the hydroxy fatty acid ester (III-A) with an ether protecting group R 7 such as tetrahydropyranyl group and ethoxyethyl group, it is reacted with an amine derivative (II) in the presence of a base catalyst, Amide derivative (I
X), and then the two hydroxy groups of the amide derivative (IX) are protected with an acetyl group or a tert-butyldiphenylsilyl group (R 8 ), and the protecting group R 7 is treated with an alcohol in the presence of an acid catalyst. Deprotection by amide derivative (XI)
And then a suitable dehydrating agent (eg, And P (C 6 H 5 ) 3 ] in the presence of a fatty acid (VII), or in the presence of a base, a fatty acid chloride (XII) to act as an amide derivative (XIII), and finally protected. Basis
When the R 8 Deprotection [R 8 is an acetyl group, a lower alcohol
A base such as K 2 CO 3 or Na 2 CO 3 is used, and when R 8 is a tert-butyldiphenylsilyl group, a fluoride ion such as tetrabutylammonium fluoride is used] to prepare an amide derivative (IC ) Get.
次に、上述の本発明のアミド誘導体を含有する本発明
の皮膚外用剤について説明する。Next, the external preparation for skin of the present invention containing the above-mentioned amide derivative of the present invention will be described.
本発明のアミド誘導体を本発明の皮膚外用剤として用
いる場合の配合量は、特に制限されないが、通常、乳化
型の皮膚外用剤の場合には全組成の0.001〜50重量%
(以下、単に%で示す)が好ましく、スクワラン等の液
状炭化水素を基剤とする油性の皮膚外用剤の場合には0.
01〜50%が好ましい。The amount of the amide derivative of the present invention to be used as the external preparation for skin of the present invention is not particularly limited, but usually 0.001 to 50% by weight of the total composition in the case of an emulsion type external preparation for skin.
(Hereinafter, simply indicated by%) is preferable, and 0 in the case of oily external preparation for skin based on liquid hydrocarbon such as squalane.
01 to 50% is preferable.
本発明の皮膚外用剤は、従来の皮膚外用剤の基剤に前
記一般式(I)で表されるアミド誘導体を含有させてな
るもので、その使用形態において、薬用皮膚外用剤と化
粧料に大別される。The skin external preparation of the present invention comprises a conventional skin external preparation base and an amide derivative represented by the general formula (I). Broadly divided.
薬用皮膚外用剤としては、例えば、薬効成分を含有す
る各種軟膏剤を挙げることができる。軟膏剤としては、
油性基剤をベースとするもの、油/水、水/油型の乳化
系基剤をベースとするもののいずれであってもよい。上
記油性基剤としては、特に制限はなく、例えば、植物
油、動物油、合成油、脂肪酸、及び天然又は合成のグリ
セライド等が挙げられる。また、上記薬効成分として
は、特に制限はなく、例えば、鎮痛消炎剤、鎮痒剤、殺
菌消毒剤、収斂剤、皮膚軟化剤、ホルモン剤等を必要に
応じて適宜使用することができる。Examples of the external medicated skin agent include various ointments containing medicinal components. As an ointment,
It may be based on an oily base, oil / water, or a water / oil type emulsion base. The oily base is not particularly limited and includes, for example, vegetable oil, animal oil, synthetic oil, fatty acid, and natural or synthetic glyceride. In addition, the medicinal component is not particularly limited, and for example, an analgesic / anti-inflammatory agent, an antipruritic agent, a bactericidal / antiseptic agent, an astringent agent, an emollient agent, a hormone agent and the like can be appropriately used as necessary.
また、化粧料として使用する場合は、必須成分である
本発明のアミド誘導体の他に、化粧料成分として一般に
使用されている油分、保湿剤、紫外線吸収剤、アルコー
ル類、キレート剤、pH調整剤、防腐剤、増粘剤、色素、
香料等を任意に組み合わせて配合することができる。When used as a cosmetic, in addition to the amide derivative of the present invention which is an essential component, oils, moisturizers, UV absorbers, alcohols, chelating agents, pH adjusters that are commonly used as cosmetic ingredients. , Preservatives, thickeners, pigments,
Fragrances and the like can be blended in any combination.
化粧料としては、種々の形態、例えば、水/油、油/
水型乳化化粧料、クリーム、化粧乳液、化粧水、油性化
粧料、口紅、ファンデーション、皮膚洗浄剤、ヘアート
ニック、整髪剤、養毛剤、育毛剤等の皮膚化粧料とする
ことができる。As cosmetics, various forms such as water / oil, oil /
It can be a skin cosmetic such as a water-based emulsified cosmetic, a cream, a cosmetic emulsion, a lotion, an oily cosmetic, a lipstick, a foundation, a skin cleanser, a hairnic, a hair styling agent, a hair nourishing agent and a hair restorer.
前記一般式(I)で表される本発明のアミド誘導体を
含有する皮膚外用剤の作用機構の詳細は完全には解明さ
れていないが、皮膚外用剤として皮膚に適用されること
により、角質細胞間の脂質膜を補強して角層のバリアー
機能を改善するものと推察される。Although the details of the mechanism of action of the external preparation for skin containing the amide derivative of the present invention represented by the general formula (I) has not been completely clarified, keratinocyte It is presumed that it strengthens the intervening lipid membrane and improves the barrier function of the stratum corneum.
次に、実施例を挙げて本発明を更に詳しく説明する。 Next, the present invention will be described in more detail with reference to examples.
実施例1 N−(2−ヒドロキシ−3−ヘキサデシロキシプロピ
ル)−N−2−ヒドロキシエチル−12−ヒドロキシオク
タデカンアミド〔前記一般式(I)においてR1=C16H33
−及び であるアミド誘導体〕(I−Aa)の合成: N−(2−ヒドロキシ−3−ヘキサデシロキシプロ
ピル)エタノールアミン(IIa)の合成: 攪拌装置、滴下漏斗、温度計及び還流冷却器を備えた
200ml4ツ口フラスコにエタノールアミン61.1g(1.0mo
l)を入れ、60〜70℃に加熱攪拌しつつ、これにヘキサ
デシルグリシジルエーテル24.3g(0.082mol)を45分か
けて滴下した。滴下終了後、更に同条件下で2時間加熱
攪拌し、未反応のエタノールアミンを減圧下に留去(79
〜81℃〜20Torr)した。残渣をシリカゲルフラッシュカ
ラムクロマトグラフィーで精製することにより、標記化
合物(IIa)18.4gを得た(収率63%)。尚、得られた化
合物の1H−NMRの測定結果は次の通りであった。1 H−NMR(δ,CDCl3): 0.85(t,3H)、1.23(bs,28H)、2.6〜2.8(m,4H)、
3.1〜3.9(m,10H) アミド誘導体(I−Aa)の合成: 攪拌装置、滴下ロート、温度計及び蒸留装置を備えた
100mlフラスコに、上記で得た化合物(IIa)17.3g(4
8m mol)及びKOH0.14g(2.5m mol)を仕込み、80℃/20T
orrで減圧下に加熱攪拌しつつ、12−ヒドロキシオクタ
デカン酸メチル15.1g(48m mol)を1時間かけて滴下し
た。滴下終了後、更に同条件下で1時間攪拌し、得られ
た粗生成物をシリカゲルフラッシュカラムクロマトグラ
フィーで精製することにより、標記化合物(I−Aa)2
3.0gを得た(収率74%)。得られた化合物の融点、IR及
び1H−NMRの測定結果は次の通りであった。Example 1 N- (2-hydroxy-3-hexadecyloxypropyl) -N-2-hydroxyethyl-12-hydroxyoctadecane amide [in the general formula (I), R 1 = C 16 H 33
-And Of amide derivative] (I-Aa): Synthesis of N- (2-hydroxy-3-hexadecyloxypropyl) ethanolamine (IIa): equipped with stirrer, dropping funnel, thermometer and reflux condenser
61.1 g of ethanolamine (1.0mo
1) was added, and while heating and stirring at 60 to 70 ° C., 24.3 g (0.082 mol) of hexadecyl glycidyl ether was added dropwise to this over 45 minutes. After completion of dropping, the mixture was further heated and stirred under the same conditions for 2 hours, and unreacted ethanolamine was distilled off under reduced pressure (79
〜81 ℃ 〜20Torr). The residue was purified by silica gel flash column chromatography to obtain 18.4 g of the title compound (IIa) (yield 63%). The 1 H-NMR measurement results of the obtained compound were as follows. 1 H-NMR (δ, CDCl 3 ): 0.85 (t, 3H), 1.23 (bs, 28H), 2.6 to 2.8 (m, 4H),
3.1-3.9 (m, 10H) Synthesis of amide derivative (I-Aa): equipped with stirrer, dropping funnel, thermometer and distillation device
In a 100 ml flask, the compound (IIa) obtained above (17.3 g (4
8m mol) and KOH 0.14g (2.5m mol) were charged, 80 ℃ / 20T
With heating and stirring under reduced pressure at orr, 15.1 g (48 mmol) of methyl 12-hydroxyoctadecanoate was added dropwise over 1 hour. After completion of the dropping, the mixture was further stirred under the same conditions for 1 hour, and the obtained crude product was purified by silica gel flash column chromatography to give the title compound (I-Aa) 2
3.0 g was obtained (74% yield). The melting point, IR and 1 H-NMR measurement results of the obtained compound were as follows.
融点:70.8〜71.3℃ IR:3352、2926、2854、1617、1473、1122、1077cm-1 1 H−NMR(δ,CDC13): 0.88(t,J=6.3Hz,6H)、1.12〜1.82(m,56H)、2.24
〜2.51(m,2H)、3.23〜4.30(m,15H) 実施例2 N−(2−ヒドロキシ−3−ヘキサデシロキシプロピ
ル)−N−2−ヒドロキシエチル−16−ヒドロキシヘキ
サデカンアミド〔前記一般式(I)においてR1=C
16H33、R3OR2=HO(CH2)15−であるアミド誘導体〕
(I−Ab)の合成: 実施例1ので得たアミン(IIa)と16−ヒドロキシ
ヘキサデカン酸メチルとを実施例1のと同様の方法で
反応させ、無色粉末の目的化合物(I−Ab)を得た(収
率75%)。得られた化合物の融点、IR及び1H−NMRの測
定結果は次の通りであった。 Mp: 70.8~71.3 ℃ IR: 3352,2926,2854,1617,1473,1122,1077cm -1 1 H-NMR (δ, CDC1 3): 0.88 (t, J = 6.3Hz, 6H), 1.12~1.82 ( m, 56H), 2.24
-2.51 (m, 2H), 3.23-4.30 (m, 15H) Example 2 N- (2-hydroxy-3-hexadecyloxypropyl) -N-2-hydroxyethyl-16-hydroxyhexadecane amide [the above general formula In (I) R 1 = C
16 H 33, R 3 OR 2 = HO (CH 2) 15 - a is an amide derivative]
Synthesis of (I-Ab): The amine (IIa) obtained in Example 1 was reacted with methyl 16-hydroxyhexadecanoate in the same manner as in Example 1 to give the target compound (I-Ab) as a colorless powder. Obtained (yield 75%). The melting point, IR and 1 H-NMR measurement results of the obtained compound were as follows.
融点:80.6〜81.5℃ IR:3370、2920、2854、1626、1596、1473、1131、106
2、723cm-1 1 H−NMR(δ,CDCl3): 0.88(t,J=6.6Hz,3H)、0.96〜1.80(m,54H)、2.30
〜2.48(m,2H)、3.24〜4.17(m,15H) 実施例3 N−(2−ヒドロキシ−3−ヘキサデシロキシプロピ
ル)−N−2−ヒドロキシエチル−16−(9Z,12Z−オク
タデカジエニロキシ)ヘキサデカンアミド〔前記一般式
(I)においてR1=C16H33及び であるアミド誘導体〕(I−Ba)の合成: 16−(9Z,12Z−オクタデカジエニロキシ)ヘキサデ
カン酸メチル(III−Ba)の合成: 攪拌装置、滴下ロート、温度計及び還流冷却器を備え
た300ml4ツ口フラスコに、16−ヒドロキシヘキサデカン
酸2.72g(10m mol)、無水テトラヒドロフラン50ml、無
水ヘキサメチルホスホリルトリアミド5ml及び水素化ナ
トリウム0.24g(10m mol)を入れ、N2気流下、室温で30
分間攪拌した。次いで、この混合物を−70℃まで冷却
し、1.6Nブチルリチウムヘキサン溶液6.25ml(10m mo
l)を加えた後、30分かけて室温まで加温し、ここで水
素化ナトリウム0.24g(10m mol)を加えてさらに30分間
室温で攪拌した。次に、ここにp−トルエンスルホン酸
9Z,12Z−オクタデカジエニルエステル9.25g(22m mol)
を滴下し、65℃で18時間加熱攪拌し、次いでこの反応混
合物に無水メタノール150mlを加え、更に65℃で1時間
攪拌した。反応混合物を室温まで冷却後、塩化アンモニ
ウム水溶液で過剰のアルカリを中和し、トルエンで反応
混合物を抽出し、溶媒を減圧留去後、残渣をフラッシュ
カラムクロマトグラフィーで精製することにより、標記
化合物(III−Ba)0.72gを得た(収率13.5%)。Melting point: 80.6-81.5 ° C IR: 3370, 2920, 2854, 1626, 1596, 1473, 1131, 106
2,723cm -1 1 H-NMR (δ , CDCl 3): 0.88 (t, J = 6.6Hz, 3H), 0.96~1.80 (m, 54H), 2.30
-2.48 (m, 2H), 3.24-4.17 (m, 15H) Example 3 N- (2-hydroxy-3-hexadecyloxypropyl) -N-2-hydroxyethyl-16- (9Z, 12Z-octadeca Dienyloxy) hexadecanamide [in the general formula (I), R 1 ═C 16 H 33 and Amide derivative] (I-Ba): Synthesis of methyl 16- (9Z, 12Z-octadecadienyloxy) hexadecanoate (III-Ba): Stirrer, dropping funnel, thermometer and reflux condenser In a 300 ml four-necked flask provided, 2.72 g (10 mmol) of 16-hydroxyhexadecanoic acid, 50 ml of anhydrous tetrahydrofuran, 5 ml of anhydrous hexamethylphosphoryltriamide and 0.24 g (10 mmol) of sodium hydride were added, and the mixture was kept at room temperature under N 2 flow. At 30
Stirred for minutes. The mixture was then cooled to -70 ° C and 6.25 ml of 1.6N butyllithium hexane solution (10 mM
l) was added, the mixture was warmed to room temperature over 30 minutes, 0.24 g (10 mmol) of sodium hydride was added, and the mixture was stirred at room temperature for another 30 minutes. Then, here p-toluenesulfonic acid
9.Z, 12Z-octadecadienyl ester 9.25g (22m mol)
Was added dropwise, and the mixture was heated with stirring at 65 ° C. for 18 hours, 150 ml of anhydrous methanol was added to the reaction mixture, and the mixture was further stirred at 65 ° C. for 1 hour. After cooling the reaction mixture to room temperature, excess alkali was neutralized with an aqueous ammonium chloride solution, the reaction mixture was extracted with toluene, the solvent was evaporated under reduced pressure, and the residue was purified by flash column chromatography to give the title compound ( III-Ba) 0.72 g was obtained (yield 13.5%).
アミド誘導体(I−Ba)の合成: 上記で得た化合物(III−Ba)と実施例1ので得
たアミン(IIa)とを実施例1のと同様の方法で反応
させ、無色粉末の目的化合物(I−Ba)を得た(収率71
%)。得られた化合物の融点、IR及び1H−NMRの測定結
果は次の通りであった。Synthesis of amide derivative (I-Ba): The compound (III-Ba) obtained above and the amine (IIa) obtained in Example 1 were reacted in the same manner as in Example 1 to give the target compound as a colorless powder. (I-Ba) was obtained (yield 71
%). The melting point, IR and 1 H-NMR measurement results of the obtained compound were as follows.
融点:63.0〜64.3℃ IR:3304、2920、2854、1614、1467、1116、1062、720
cm-1 1 H−NMR(δ,CDC13): 0.80〜0.95(m,6H)、0.95〜1.70(m,72H)、1.95〜
2.12(m,4H)、2.39(t,J=7.7Hz,2H)、2.77(bt,J=
5.7Hz,2H)、3.39(t,J=6.6Hz,4H)、3.23〜4.23(m,1
3H)、5.24〜5.44(m,4H) 実施例4 N−(2−ヒドロキシ−3−ヘキサデシロキシプロピ
ル)−N−2−ヒドロキシエチル−16−(9Z,12Z−オク
タデカジエノイルオキシ)ヘキサデカンアミド〔前記一
般式(I)においてR1=C16H33 -及び であるアミド誘導体〕(I−Ca)の合成: 16−(9Z,12Z−オクタデカジエノイルオキシ)ヘキ
サデカン酸メチル(III−Ca)の合成: 攪拌装置、滴下ロート及び温度計を備えた300mlフラ
スコに、16−ヒドロキシヘキサデカン酸メチル4.30g(1
5m mol)、リノール酸8.41g(13m mol)、トリフェニル
ホスフィン7.87g(30m mol)及びテトラヒドロフラン10
0mlを仕込み、室温で攪拌下にアゾジカルボン酸ジエチ
ル5.22g(30m mol)を1時間かけて滴下した。滴下終了
後、更に室温で4時間攪拌した後、溶媒を減圧下に留去
し、残渣をシリカゲルフラッシュクロマトグラフィーで
精製することにり、標記化合物(III−Ca)6.76gを得た
(収率82%)。Melting point: 63.0-64.3 ° C IR: 3304, 2920, 2854, 1614, 1467, 1116, 1062, 720
cm -1 1 H-NMR (δ , CDC1 3): 0.80~0.95 (m, 6H), 0.95~1.70 (m, 72H), 1.95~
2.12 (m, 4H), 2.39 (t, J = 7.7Hz, 2H), 2.77 (bt, J =
5.7Hz, 2H), 3.39 (t, J = 6.6Hz, 4H), 3.23 to 4.23 (m, 1
3H), 5.24-5.44 (m, 4H) Example 4 N- (2-hydroxy-3-hexadecyloxypropyl) -N-2-hydroxyethyl-16- (9Z, 12Z-octadecadienoyloxy) hexadecane R 1 = C 16 H 33 in the amide [the general formulas (I) - and Of amide derivative] (I-Ca): Synthesis of methyl 16- (9Z, 12Z-octadecadienoyloxy) hexadecanoate (III-Ca): 300 ml flask equipped with stirrer, dropping funnel and thermometer In addition, 4.30 g of methyl 16-hydroxyhexadecanoate (1
5m mol), linoleic acid 8.41g (13m mol), triphenylphosphine 7.87g (30m mol) and tetrahydrofuran 10
0 ml was charged, and 5.22 g (30 mmol) of diethyl azodicarboxylate was added dropwise over 1 hour with stirring at room temperature. After completion of the dropwise addition, the mixture was further stirred at room temperature for 4 hours, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel flash chromatography to obtain 6.76 g of the title compound (III-Ca) (yield 82%).
アミド誘導体(I−Ca)の合成: 攪拌装置、滴下ロート、温度計及び蒸溜装置を備えた
50mlフラスコに、上記で得た化合物(III−Ca)2.74g
(5m mol)、実施例1ので得たアミン(IIa)1.80g
(5m mol)及びカリウムtert−ブトキシド0.028g(0.25
m mol)を仕込み、80℃/20Torrの減圧下で30分間加熱攪
拌した。得られた粗生成物をシリカゲルカラムクロマト
グラフィー及びゲルクロマトグラフィーで精製すること
により、標記化合物(I−Ca)1.65gを得た(収率38
%)。得られた化合物の融点、IR、1H−NMR及びMSの測
定結果は次の通りであった。Synthesis of amide derivative (I-Ca): equipped with stirrer, dropping funnel, thermometer and distillation device
2.74 g of the compound (III-Ca) obtained above in a 50 ml flask.
(5 mmol), 1.80 g of amine (IIa) obtained in Example 1
(5m mol) and potassium tert-butoxide 0.028g (0.25
(mol mol) was charged and the mixture was heated and stirred for 30 minutes under reduced pressure of 80 ° C./20 Torr. The obtained crude product was purified by silica gel column chromatography and gel chromatography to obtain 1.65 g of the title compound (I-Ca) (yield 38
%). The measurement results of melting point, IR, 1 H-NMR and MS of the obtained compound were as follows.
融点:58.2〜58.9℃ IR:3304、2920、2856、1734、1612、1464、1440、121
6、1166、1108、756、720cm-1 1H−NMR(δ,CDCl3): 0.80〜1.00(m,6H)、1.00〜1.73(m,70H)、1.95〜
2.16(m,4H)、2.28(t,J=7.5Hz,2H)、2.39(bt,J=
7.7Hz,2H)、2.77(bt,J=5.9Hz,2H)、3.23〜4.25(m,
13H)、4.05(t,J=6.6Hz,2H)、5.26〜5.47(m,4H) MS(FAB,POS): 877(M+1)、859、634、596、360 (FAB,NEG): 875(M−1)、873、831、613、534、359、305、279 実施例5 N−(2−ヒドロキシ−3−ヘキサデシロキシプロピ
ル)−N−2−ヒドロキシエチル−16−(9Z−オクタデ
セノイルオキシ)ヘキサデカンアミド〔前記一般式
(I)において、R1=C16H33−及び であるアミド誘導体〕(I−Cb)の合成: N−(2−ヒドキシ−3−ヘキサデシロキシプロピ
ル)−N−2−ヒドロキシエチル−16−(2−テトラヒ
ドロピラニルオキシ)ヘキサデカンアミド(IX−b)の
合成: 攪拌装置及び滴下ロートを備えた1フラスコに、16
−ヒドロキシヘキサデカン酸メチル100.26g(0.35mo
l)、p−トルエンスルホン酸0.60g(3.5m mol)及びジ
クロロメタン350mlを仕込み、0℃にて攪拌しながらジ
ヒドロピラン32.39g(0.385mol)を滴下した。滴下終了
後、1時間室温で攪拌して反応を完結させた。次いで、
反応混合物にNaHCO30.59g(7m mol)を加えて中和し、
濾過、溶媒留去して、16−(2−テトラヒドロピラニル
オキシ)ヘキサデカン酸メチル粗製物を得た。Melting point: 58.2-58.9 ° C IR: 3304, 2920, 2856, 1734, 1612, 1464, 1440, 121
6,1166,1108,756,720cm -1 1 H-NMR (δ , CDCl 3): 0.80~1.00 (m, 6H), 1.00~1.73 (m, 70H), 1.95~
2.16 (m, 4H), 2.28 (t, J = 7.5Hz, 2H), 2.39 (bt, J =
7.7Hz, 2H), 2.77 (bt, J = 5.9Hz, 2H), 3.23 to 4.25 (m,
13H), 4.05 (t, J = 6.6Hz, 2H), 5.26 to 5.47 (m, 4H) MS (FAB, POS): 877 (M + 1), 859, 634, 596, 360 (FAB, NEG): 875 ( M-1), 873, 831, 613, 534, 359, 305, 279 Example 5 N- (2-hydroxy-3-hexadecyloxypropyl) -N-2-hydroxyethyl-16- (9Z-octade Cenoyloxy) hexadecanamide [in the general formula (I), R 1 = C 16 H 33 -and Is an amide derivative] (I-Cb): N- (2-hydroxy-3-hexadecyloxypropyl) -N-2-hydroxyethyl-16- (2-tetrahydropyranyloxy) hexadecanamide (IX- Synthesis of b): In one flask equipped with a stirrer and dropping funnel, 16
-Methyl hydroxyhexadecanoate 100.26g (0.35mo
l), 0.60 g (3.5 mmol) of p-toluenesulfonic acid and 350 ml of dichloromethane were charged, and 32.39 g (0.385 mol) of dihydropyran was added dropwise with stirring at 0 ° C. After completion of dropping, the reaction was completed by stirring at room temperature for 1 hour. Then
The reaction mixture was neutralized by adding 0.59 g (7 mmol) of NaHCO 3 .
Filtration and evaporation of the solvent gave a crude product of methyl 16- (2-tetrahydropyranyloxy) hexadecanoate.
次に、攪拌装置、滴下ロート、温度計及び蒸留装置を
備えた1フラスコに、実施例1ので得られたN−
(2−ヒドロキシ−3−ヘキサデシロキシプロピル)エ
タノールアミン(IIa)125.9g(0.35mol)及びKOH0.98g
(17.5m mol)を仕込み、80℃/20Torrの減圧下に加熱攪
拌しつつ、上記で得た16−(2−テトラヒドロピラニル
オキシ)ヘキサデカン酸メチル粗製物を2時間かけて滴
下し、生成してくるメタノールを留去した。滴下終了
後、更に同条件下で2時間攪拌し、得られた粗生成物を
メタノールより再結晶することにより、化合物(IX−
b)212.3gを得た(収率86.9%)。Next, in one flask equipped with a stirrer, a dropping funnel, a thermometer and a distillation device, the N-obtained in Example 1
(2-Hydroxy-3-hexadecyloxypropyl) ethanolamine (IIa) 125.9 g (0.35 mol) and KOH 0.98 g
(17.5 mmol) was charged, and the crude product of methyl 16- (2-tetrahydropyranyloxy) hexadecanoate obtained above was added dropwise over 2 hours while stirring with heating under reduced pressure of 80 ° C./20 Torr to produce The incoming methanol was distilled off. After completion of dropping, the mixture was further stirred under the same conditions for 2 hours, and the obtained crude product was recrystallized from methanol to give the compound (IX-
b) 212.3 g was obtained (yield 86.9%).
N−(2−(tert−ブチルジフェニルシリルオキ
シ)−3−ヘキサデシロキシプロピル)−N−2−(te
rt−ブチルジフェニルシリルオキシ)エチル−16−ヒド
ロキシヘキサデカンアミド(X1−b)の合成: 攪拌装置及び滴下ロートを備えた1フラスコに、上
記で得た化合物(IX−b)34.91g(0.05mol)、イミ
ダゾール13.62g(0.2mol)及びジメチルホルムアミド35
0mlを仕込み、室温で攪拌しながらtert−ブチルジフェ
ニルクロロシラン30.24g(0.11mol)を滴下し、50℃に
加温して14時間攪拌した。反応終了後、反応混合物をジ
エチルエーテルで抽出し、食塩水で洗浄後、溶媒を減圧
留去した。N- (2- (tert-butyldiphenylsilyloxy) -3-hexadecyloxypropyl) -N-2- (te
Synthesis of rt-butyldiphenylsilyloxy) ethyl-16-hydroxyhexadecanamide (X1-b): In one flask equipped with a stirrer and a dropping funnel, 34.91 g (0.05 mol) of the compound (IX-b) obtained above was obtained. , Imidazole 13.62g (0.2mol) and dimethylformamide 35
0 ml was charged, 30.24 g (0.11 mol) of tert-butyldiphenylchlorosilane was added dropwise with stirring at room temperature, and the mixture was heated to 50 ° C. and stirred for 14 hours. After completion of the reaction, the reaction mixture was extracted with diethyl ether, washed with brine, and the solvent was evaporated under reduced pressure.
次に、上記で得られた残渣を攪拌装置を備えた1フ
ラスコに仕込み、ここにエタノール550ml、メタノール1
50ml及びパラトルエンスルホン酸ピリジニウム2.36g
(9.4m mol)を加え、室温で28時間攪拌した。反応終了
後、NaHCO3で中和し、ジエチルエーテルで反応混合物を
抽出し、溶媒を減圧留去後、残渣をシリカゲルフラッシ
ュカラムクロマトグラフィーで精製することにより、化
合物(XI−b)39.5gを得た(収率72.4%)。Next, the residue obtained above was charged into one flask equipped with a stirrer, and 550 ml of ethanol and 1 ml of methanol were charged therein.
50 ml and pyridinium paratoluenesulfonate 2.36 g
(9.4 mmol) was added, and the mixture was stirred at room temperature for 28 hours. After completion of the reaction, the reaction mixture was neutralized with NaHCO 3 , the reaction mixture was extracted with diethyl ether, the solvent was evaporated under reduced pressure, and the residue was purified by silica gel flash column chromatography to obtain 39.5 g of compound (XI-b). (Yield 72.4%).
アミド誘導体(I−Cb)の合成: 攪拌装置及び滴下ロートを備えた200mlフラスコに、
上記で得た化合物(XI−b)4.25g(3.9m mol)、ピ
リジン1.23g(15.6m mol)及びジクロロメタン50mlを仕
込み、室温で攪拌しながら塩化オレオイル1.41g(4.7m
mol)を滴下した。滴下終了後さらに1時間室温で攪拌
して反応を完結させ、反応混合物を水で洗浄し、溶媒を
減圧留去後、シリカゲルショートカラムクロマトグラフ
ィーで高極性副生成物を除去し、粗生成物を得た。Synthesis of amide derivative (I-Cb): In a 200 ml flask equipped with a stirrer and a dropping funnel,
4.25g (3.9m mol) of the compound (XI-b) obtained above, 1.23g (15.6m mol) of pyridine and 50ml of dichloromethane were charged, and 1.41g (4.7m) of oleoyl chloride was stirred with stirring at room temperature.
mol) was added dropwise. After completion of the dropwise addition, the reaction was completed by stirring at room temperature for 1 hour, the reaction mixture was washed with water, the solvent was distilled off under reduced pressure, and the highly polar by-product was removed by silica gel short column chromatography to obtain a crude product. Obtained.
次に、上記で得られた粗生成物を攪拌装置を備えた20
0mlフラスコに仕込み、ここにテトラヒドロフラン50ml
及びフッ化テトラブチルアンモニウム2.46g(7.8m mo
l)を加え、室温で30分攪拌した。反応終了後、反応混
合物をクロロホルムで抽出し、食塩水で洗浄後、溶媒を
減圧留去し、残渣をシリカゲルフラッシュカラムクロマ
トグラフィーで精製することにより、標記化合物(I−
Cb)2.67gを得た(収率77.9%)。得られた化合物の融
点、IR及び1H−NMRの測定結果は次の通りであった。Next, the crude product obtained above was mixed with a stirrer 20
Charge into a 0 ml flask and add 50 ml of tetrahydrofuran here.
And tetrabutylammonium fluoride 2.46g (7.8m mo
l) was added, and the mixture was stirred at room temperature for 30 minutes. After completion of the reaction, the reaction mixture was extracted with chloroform, washed with brine, the solvent was evaporated under reduced pressure, and the residue was purified by silica gel flash column chromatography to give the title compound (I-
Cb) 2.67 g was obtained (yield 77.9%). The melting point, IR and 1 H-NMR measurement results of the obtained compound were as follows.
融点:60.4〜61.3℃ IR:3304、2920、2854、1737、1617、1467、1443、119
1、1110、1062、723cm-1 1 H−NMR(δ,CDCl3): 0.88(t,J=6.4Hz,6H)、1.10〜1.85(m,76H)、1.85
〜2.10(m,4H)、2.29(t,J=7.5Hz,2H)、2.39(bt,J
=7.6Hz,2H)、3.21〜4.20(m,13H)、4.05(t,J=6.7H
z,2H)、5.34(bt,J=5.3Hz,2H) 実施例6 N−(2−ヒドロキシ−3−ヘキサデシロキシプロピ
ル)−N−2−ヒドロキシエチル−16−(メチルペプタ
デシルオキシ)ヘキサデカンアミド〔前記一般式(I)
において、R1=C16H33−及び (式中、pはp=7を頂点とする分布を有する整数を表
わす)であるアミド誘導体〕(I−Cc)の合成: 実施例5のにおいて、塩化オレオイルの代わりに塩
化メチルヘプタデシルを用いる以外は実施例5と同様に
反応を行って、目的化合物(I−Cc)を得た(収率65.5
%)。得られた化合物の融点、IR及び1H−NMRの測定結
果は次の通りであった。Melting point: 60.4-61.3 ° C IR: 3304, 2920, 2854, 1737, 1617, 1467, 1443, 119
1,1110,1062,723cm -1 1 H-NMR (δ , CDCl 3): 0.88 (t, J = 6.4Hz, 6H), 1.10~1.85 (m, 76H), 1.85
~ 2.10 (m, 4H), 2.29 (t, J = 7.5Hz, 2H), 2.39 (bt, J
= 7.6Hz, 2H), 3.21 ~ 4.20 (m, 13H), 4.05 (t, J = 6.7H
z, 2H), 5.34 (bt, J = 5.3Hz, 2H) Example 6 N- (2-hydroxy-3-hexadecyloxypropyl) -N-2-hydroxyethyl-16- (methylpeptadecyloxy) Hexadecanamide [the above general formula (I)
Where R 1 = C 16 H 33 − and (Wherein p represents an integer having a distribution with p = 7 at the apex)] (I-Cc) Synthesis: In Example 5, methylheptadecyl chloride was used instead of oleoyl chloride. The reaction was performed in the same manner as in Example 5 except that the target compound (I-Cc) was obtained (yield: 65.5).
%). The melting point, IR and 1 H-NMR measurement results of the obtained compound were as follows.
融点:60.1〜62.0℃ IR:3298、2926、2380、1737、1614、1467、1443、120
3、1110、1059、720cm-1 1 H−NMR(δ,CDCl3): 0.77〜1.00(m,9H)、1.03〜1.75(m,81H)、2.29
(t,J=7.5Hz,2H)、2.40(bt,J=7.3Hz,2H)、3.24〜
4.33(m,13H)、4.05(t,J=6.6Hz,2H) 実施例7 N−(2−ヒドロキシ−3−ヘキサデシロキシプロピ
ル)−N−2−ヒドロキシエチル−32−(9Z,12Z−オク
タデカジエノイルオキシ)ドトリアコンタンアミド〔前
記一般式(I)において、R1=C16H33−及び であるアミド誘導体〕(I−Cd)の合成; 実施例5のにおいて、16−ヒドロキシヘキサデカン
酸メチルの代わりに32−ヒドロキシドトリアコンタン酸
メチルを用い、且つ実施例5のにおいて、塩化オレオ
イルの代わりに塩化リノレオイルを用いる以外は実施例
5と同様に反応を行って、目的化合物(I−Cd)を得た
(収率24.8%)。得られた化合物の融点、IR及び1H−NM
Rの測定結果は次の通りであった。Melting point: 60.1-62.0 ° C IR: 3298, 2926, 2380, 1737, 1614, 1467, 1443, 120
3,1110,1059,720cm -1 1 H-NMR (δ , CDCl 3): 0.77~1.00 (m, 9H), 1.03~1.75 (m, 81H), 2.29
(T, J = 7.5Hz, 2H), 2.40 (bt, J = 7.3Hz, 2H), 3.24 ~
4.33 (m, 13H), 4.05 (t, J = 6.6Hz, 2H) Example 7 N- (2-hydroxy-3-hexadecyloxypropyl) -N-2-hydroxyethyl-32- (9Z, 12Z- Octadecadienoyloxy) dotriacontanamide [in the general formula (I), R 1 ═C 16 H 33 − and Synthesis of amide derivative] (I-Cd); In Example 5, methyl 16-hydroxyhexadecanoate was replaced with methyl 32-hydroxydotriacontanate, and in Example 5, oleoyl chloride The reaction was performed in the same manner as in Example 5 except that linoleoyl chloride was used instead to obtain the target compound (I-Cd) (yield 24.8%). Melting point, IR and 1 H-NM of the obtained compound
The measurement result of R was as follows.
融点:72.4〜73.0℃ IR:3304、2920、2852、1738、1614、1466、1442、116
8、1112、1062、760、722cm-1 1 H−NMR(δ,CDCl3): 0.81〜1.01(m,6H)、1.10〜1.72(m,92H)、1.95〜
2.15(m,4H)、2.29(t,J=7.5Hz,2H)、2.39(bt,J=
7.6Hz,2H)、2.77(bt,J=5.7Hz,2H)、3.18〜4.20(m,
13H)、4.05(t,J=6.7Hz,2H)、5.23〜5.46(m,4H) 実施例8 N−(2−ヒドロキシ−3−ヘキサデシロキシプロピ
ル)−N−2−ヒドロキシエチル−16−(12−ヒドロキ
シオクタデカノイルオキシ)ヘキサデカンアミド〔前記
一般式(I)において、R1=C16H33−及び であるアミド誘導体〕(I−Ce)の合成: 12−(tert−ブチルジメチルシリルオキシ)オクタデ
カン酸の合成; 攪拌装置及び滴下ロートを備えた100mlフラスコに、1
2−ヒドロキシオクタデカン酸エチル3.28g(10m mo
l)、イミダゾール1.36g(20m mol)及びジメチルホル
ムアミド50mlを仕込み、室温で攪拌しながらtert−ブチ
ルジメチルクロロシラン1.66g(11m mol)を滴下した。
滴下終了後、反応混合物を50℃で18時間攪拌し、反応を
終了させた。次いで、反応混合物をエーテルで抽出し、
食塩水で洗浄後、溶媒を減圧留去し、残渣をシリカゲル
フラッシュクロマトグラフィーで精製して、12−(tert
−ブチルジメチルシリルオキシ)オクタデカン酸エチル
を得た。Melting point: 72.4-73.0 ° C IR: 3304, 2920, 2852, 1738, 1614, 1466, 1442, 116
8,1112,1062,760,722cm -1 1 H-NMR (δ , CDCl 3): 0.81~1.01 (m, 6H), 1.10~1.72 (m, 92H), 1.95~
2.15 (m, 4H), 2.29 (t, J = 7.5Hz, 2H), 2.39 (bt, J =
7.6Hz, 2H), 2.77 (bt, J = 5.7Hz, 2H), 3.18-4.20 (m,
13H), 4.05 (t, J = 6.7Hz, 2H), 5.23 to 5.46 (m, 4H) Example 8 N- (2-hydroxy-3-hexadecyloxypropyl) -N-2-hydroxyethyl-16- (12-Hydroxyoctadecanoyloxy) hexadecanamide [in the above general formula (I), R 1 = C 16 H 33 -and Synthesis of amide derivative] (I-Ce): 12- (tert-butyldimethylsilyloxy) octadecanoic acid; 1 ml in a 100 ml flask equipped with a stirrer and a dropping funnel.
Ethyl 2-hydroxyoctadecanoate 3.28 g (10 m mo
l), 1.36 g (20 mmol) of imidazole and 50 ml of dimethylformamide were charged, and 1.66 g (11 mmol) of tert-butyldimethylchlorosilane was added dropwise while stirring at room temperature.
After completion of the dropping, the reaction mixture was stirred at 50 ° C. for 18 hours to terminate the reaction. The reaction mixture is then extracted with ether,
After washing with brine, the solvent was evaporated under reduced pressure and the residue was purified by silica gel flash chromatography to give 12- (tert
Ethyl -butyldimethylsilyloxy) octadecanoate was obtained.
次に、上記で得た12−(tert−ブチルジメチルシリル
オキシ)オクタデカン酸エチルを攪拌装置を備えた100m
lのフラスコに仕込み、ここにエタノール20ml及び50%K
OH水溶液2.24g(20m mol)を加え、室温で4時間攪拌し
た。反応終了後、得られた反応混合物を塩酸で中和後、
クロロホルムで抽出し、溶媒を減圧留去して、12−(te
rt−ブチルジメチルシリルオキシ)オクタデカン酸4.0g
を得た(収率96.4%)。Next, ethyl 12- (tert-butyldimethylsilyloxy) octadecanoate obtained above was added to 100 m equipped with a stirrer.
Place in a l-flask and add 20 ml of ethanol and 50% K to it.
2.24 g (20 mmol) of an OH aqueous solution was added, and the mixture was stirred at room temperature for 4 hours. After the reaction was completed, the obtained reaction mixture was neutralized with hydrochloric acid,
Chloroform extracted, the solvent was distilled off under reduced pressure, and 12- (te
rt-Butyldimethylsilyloxy) octadecanoic acid 4.0 g
Was obtained (yield 96.4%).
アミド誘導体(I−Ce)の合成: 攪拌装置、滴下ロート及び温度計を備えた100mlフラ
スコに、上記で得た12−(tert−ブチルジメチルシリ
ルオキシ)オクタデカン酸1.87g(4.5m mol)、実施例
5ので得た化合物(XI−b)3.27g(3m mol)、トリ
フェニルホスフィン1.18g(4.5m mol)及びテトラヒド
ロフラン10mlを仕込み、室温で攪拌下にアゾジカルボン
酸ジエチル0.71g(4.05m mol)のテトラヒドロフラン5m
l溶液を5分間かけて滴下した。滴下終了後更に室温で
4時間攪拌した後、溶媒を減圧下で留去し、残渣をシリ
カゲルフラッシュカラムクロマトグラフィーで精製し
た。Synthesis of amide derivative (I-Ce): In a 100 ml flask equipped with a stirrer, a dropping funnel and a thermometer, 1.87 g (4.5 mmol) of 12- (tert-butyldimethylsilyloxy) octadecanoic acid obtained above was used. 3.27 g (3 mmol) of the compound (XI-b) obtained in Example 5, 3.18 g (4.5 mmol) of triphenylphosphine and 10 ml of tetrahydrofuran were charged, and 0.71 g (4.05 mmol) of diethyl azodicarboxylate was stirred at room temperature. Tetrahydrofuran 5m
The solution was added dropwise over 5 minutes. After completion of the dropping, the mixture was further stirred at room temperature for 4 hours, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel flash column chromatography.
次に、上記で得られた中間体を攪拌装置を備えた100m
lフラスコに仕込み、ここにテトラヒドロフラン60ml及
びフッ化テトラブチルアンモニウム3.24g(10.3m mol)
を加え、60℃で24時間加熱攪拌した。次いで、得られた
反応混合物をクロロホルムで抽出し、食塩水で洗浄後、
溶媒を減圧留去し、残渣をシリカゲルフラッシュカラム
クロマトグラフィーで精製することにより、標記化合物
(I−Ce)0.63gを得た(収率23.4%)。得られた化合
物の融点、IR及び1H−NMRの測定結果は次の通りであっ
た。Next, 100 m of the intermediate obtained above was equipped with a stirrer.
l Charge to a flask, and add 60 ml of tetrahydrofuran and 3.24 g (10.3 mmol) of tetrabutylammonium fluoride.
Was added and the mixture was heated with stirring at 60 ° C. for 24 hours. Then, the obtained reaction mixture was extracted with chloroform, washed with saline,
The solvent was distilled off under reduced pressure, and the residue was purified by silica gel flash column chromatography to obtain 0.63 g of the title compound (I-Ce) (yield 23.4%). The melting point, IR and 1 H-NMR measurement results of the obtained compound were as follows.
融点:71.7〜73.7℃ IR:3336、2920、2852、1740、1620、1470、1180、111
6、1060、722cm-1 1 H−NMR(δ,CDCl3): 0.89(bt,J=6.2Hz,6H)、1.07〜2.00(m,82H)、2.3
0(t,J=7.5Hz,2H)、2.40(bt,J=7.6Hz,2H)、3.22〜
4.21(m,15H)、4.06(t,J=6.6Hz,2) 実施例9 N−(2−ヒドロキシ−3−ヘキサデシロキシプロピ
ル)−N−2−ヒドロキシエチル−16−(9,10,12−ト
リヒドロキシオクタデカノイルオキシ)ヘキサデカンア
ミド〔前記一般式(I)において、R1=C16H33−及び であるアミド誘導体〕(I−Cf)の合成: 実施例8のにおいて、12−ヒドロキシオクタデカン
酸エチルの代わりに9,10,12−トリヒドロキシオクタデ
カン酸エチルを用いる以外は実施例8と同様に反応を行
って、目的化合物(I−Cf)を得た(収率32.7%)。得
られた化合物の融点、IR及び1H−NMRの測定結果は次の
通りであった。Melting point: 71.7-73.7 ° C IR: 3336, 2920, 2852, 1740, 1620, 1470, 1180, 111
6,1060,722cm -1 1 H-NMR (δ , CDCl 3): 0.89 (bt, J = 6.2Hz, 6H), 1.07~2.00 (m, 82H), 2.3
0 (t, J = 7.5Hz, 2H), 2.40 (bt, J = 7.6Hz, 2H), 3.22 ~
4.21 (m, 15H), 4.06 (t, J = 6.6Hz, 2) Example 9 N- (2-hydroxy-3-hexadecyloxypropyl) -N-2-hydroxyethyl-16- (9,10, 12-trihydroxyoctadecanoyloxy) hexadecanamide [in the general formula (I), R 1 = C 16 H 33 -and Synthesis of amide derivative] (I-Cf): Reaction similar to that in Example 8 except that ethyl 9,10,12-trihydroxyoctadecanoate was used in place of ethyl 12-hydroxyoctadecanoate in Example 8. Was performed to obtain the target compound (I-Cf) (yield 32.7%). The melting point, IR and 1 H-NMR measurement results of the obtained compound were as follows.
融点:75.8〜79.2℃ IR:3300、2924、2856、1728、1620、1470、1178、112
0、1070、722cm-1 1 H−NMR(δ,CDCl3): 0.82〜1.02(m,6H)、1.15〜2.30(m,78H)、2.30
(t,J=7.4Hz,2H)、2.41(bt,J=7.6Hz,2H)、3.22〜
4.26(m,19H)、4.07(t,J=6.6Hz,2H) 実施例10 N−(2−ヒドロキシ−3−ヘキサデシロキシプロピ
ル)−N−2−ヒドロキシエチル−12−(9Z,12Z−オク
タデカジエノイルオキシ)ドデカンアミド〔前記一般式
(I)において、R1=C16H33−及び であるアミド誘導体〕(I−Cg)の合成: N−(2−ヒドロキシ−3−ヘキサデシロキシプロピ
ル)−N−2−ヒドロキシエチル−12−(2−テトラヒ
ドロピラニルオキシ)ドデカンアミド(IX−g)の合
成: 実施例5のにおいて、16−ヒドロキシヘキサデカン
酸メチルの代わりに12−ヒドロキシドデカン酸メチルを
用いた以外は実施例5のと同様にして目的化合物(IX
−g)を得た(収率67.8%)。Melting point: 75.8-79.2 ° C IR: 3300, 2924, 2856, 1728, 1620, 1470, 1178, 112
0,1070,722cm -1 1 H-NMR (δ , CDCl 3): 0.82~1.02 (m, 6H), 1.15~2.30 (m, 78H), 2.30
(T, J = 7.4Hz, 2H), 2.41 (bt, J = 7.6Hz, 2H), 3.22〜
4.26 (m, 19H), 4.07 (t, J = 6.6Hz, 2H) Example 10 N- (2-hydroxy-3-hexadecyloxypropyl) -N-2-hydroxyethyl-12- (9Z, 12Z- Octadecadienoyloxy) dodecanamide [in the general formula (I), R 1 = C 16 H 33 -and Of amide derivative] (I-Cg): N- (2-hydroxy-3-hexadecyloxypropyl) -N-2-hydroxyethyl-12- (2-tetrahydropyranyloxy) dodecane amide (IX- Synthesis of g): In the same manner as in Example 5, except that methyl 12-hydroxydodecanoate was used in place of methyl 16-hydroxyhexadecanoate in Example 5, the target compound (IX
-G) was obtained (yield 67.8%).
N−(2−アセトキシ−3−ヘキサデシロキシプロピ
ル)−N−2−アセトキシエチル−12−ヒドロキシドデ
カンアミド(XI−g)の合成: 攪拌装置及び滴下ロートを備えた1フラスコに、上
記で得た化合物(IX−g)167.0g(0.23mol)、ピリ
ジン91.0g(1.15mol)及びジクロロメタン440mlを仕込
み、0℃で攪拌下に塩化アセチル45.1g(0.575mol)を
1.5時間かけて滴下した。滴下終了後、更に1時間反応
を行い、反応を完結させた。次いで、この反応混合物に
メタノール7.4g(0.23mol)を加えて過剰の塩化アセチ
ルを反応させ、得られた混合物を、水、2N−塩酸及び食
塩水で洗浄し、溶媒を留去した。Synthesis of N- (2-acetoxy-3-hexadecyloxypropyl) -N-2-acetoxyethyl-12-hydroxydodecanamide (XI-g): Obtained as above in one flask equipped with stirrer and dropping funnel. 167.0 g (0.23 mol) of compound (IX-g), 91.0 g (1.15 mol) of pyridine and 440 ml of dichloromethane were charged, and 45.1 g (0.575 mol) of acetyl chloride was added with stirring at 0 ° C.
It was added dropwise over 1.5 hours. After completion of the dropping, the reaction was further continued for 1 hour to complete the reaction. Then, 7.4 g (0.23 mol) of methanol was added to this reaction mixture to react with excess acetyl chloride, and the obtained mixture was washed with water, 2N-hydrochloric acid and brine, and the solvent was evaporated.
次に、上記で得られた中間体を攪拌装置を備えた1
フラスコに仕込み、ここにメタノール368g(0.115mol)
及びパラトルエンスルホン酸ピリジニウム1.16g(4.6m
mol)を加えて40℃で5時間攪拌した。反応終了後、NaH
CO30.76g(9.2m mol)を加えて中和し、メタノールを留
去後、残渣をクロロホルムに溶解させ、食塩水で洗浄
し、溶媒を減圧留去し、残渣をシリカゲルショートカラ
ムクロマトグラフィーで精製して、目的化合物(XI−
g)118.3gを得た(収率80.1%)。Next, the intermediate product obtained above was placed in a stirrer 1
Put in a flask, and 368g of methanol (0.115mol)
And 1.16 g of pyridinium paratoluenesulfonate (4.6 m
mol) was added and the mixture was stirred at 40 ° C. for 5 hours. After the reaction, NaH
After neutralizing by adding 0.76g (9.2mmol) of CO 3 , methanol was distilled off, the residue was dissolved in chloroform, washed with brine, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel short column chromatography. After purification, the target compound (XI-
g) 118.3 g was obtained (yield 80.1%).
アミド誘導体(I−Cg)の合成: 攪拌装置及び滴下ロートを備えた1フラスコに、上
記で得た化合物(XI−g)73.6g(0.115mol)、ジク
ロロメタン160ml及びピリジン21.8g(0.276mol)を仕込
み、0℃で攪拌下に塩化リノレオイル41.2g(0.138mo
l)を30分かけて滴下し、滴下終了後更に2時間攪拌し
た。次にここにメタノール1.6g(0.05mol)を加えて過
剰の塩化リノレオイルをリノール酸メチルとした後、反
応混合物を食塩水で洗浄し、溶媒を減圧留去し、残渣を
シリカゲルショートカラムクロマトグラフィーで精製し
た。Synthesis of amide derivative (I-Cg): In one flask equipped with a stirrer and a dropping funnel, 73.6 g (0.115 mol) of the compound (XI-g) obtained above, 160 ml of dichloromethane and 21.8 g (0.276 mol) of pyridine were added. Charge and stir at 0 ° C with linoleoyl chloride 41.2g (0.138mo
l) was added dropwise over 30 minutes, and after the addition was completed, the mixture was stirred for 2 hours. Next, 1.6 g (0.05 mol) of methanol was added to this to make excess linoleoyl chloride methyl linoleate, the reaction mixture was washed with brine, the solvent was distilled off under reduced pressure, and the residue was subjected to silica gel short column chromatography. Purified.
次に、上記で得た中間体を攪拌装置を備えた3lフラス
コに仕込み、ここにエタノール1、メタノール0.5l及
びK2CO329.4g(0.213mol)を加えて0〜10℃で1時間攪
拌した。反応終了後、水を加えて生成している塩を溶解
させ、ジイソプロピルエーテルで反応混合物を抽出し、
食塩水で洗浄し、溶媒を減圧留去後、残渣をシリカゲル
フラッシュカラムクロマトグラフィーで精製することに
より、標記化合物(I−Cg)62.0gを得た(収率65.7
%)。得られた化合物の融点、IR及び1H−NMRの測定結
果は次の通りであった。Next, the intermediate obtained above was charged into a 3 l flask equipped with a stirrer, ethanol 1, methanol 0.5 l and K 2 CO 3 29.4 g (0.213 mol) were added thereto, and the mixture was stirred at 0 to 10 ° C for 1 hour. did. After the reaction was completed, water was added to dissolve the generated salt, and the reaction mixture was extracted with diisopropyl ether,
The extract was washed with brine, the solvent was evaporated under reduced pressure, and the residue was purified by silica gel flash column chromatography to obtain 62.0 g of the title compound (I-Cg) (yield 65.7).
%). The melting point, IR and 1 H-NMR measurement results of the obtained compound were as follows.
融点:50.6〜52.8℃ IR:3304、2924、2856、1734、1616、1470、1176、110
8、1060、720cm-1 1 H−NMR(δ,CDCl3): 0.82〜0.95(m,6H)、1.13〜1.74(m,62H)、1.96〜
2.13(m,4H)、2.29(t,J=7.5Hz,2H)、2.39(bt,J=
7.6Hz,2H)、2.77(bt,J=5.7Hz,2H)、3.22〜4.21(m,
13H)、4.05(t,J=6.71Hz,2H)、5.23〜5.48(m,4H) 実施例11 N−(2−ヒドロキシ−3−ヘキサデシロキシプロピ
ル)−N−2−ヒドロキシエチル−15−(9Z,12Z−オク
タデカジエノイルオキシ)ペンタデカンアミド〔前記一
般式(I)において、R1=C16H33−及び であるアミド誘導体〕(I−Ch)の合成: 実施例10のにおいて、12−ヒドロキシドデカン酸メ
チルの代わりに15−ヒドロキシペンタデカン酸メチルを
用いた以外は実施例10と同様に反応を行って、目的化合
物(I−Ch)を得た(収率42.3%)。得られた化合物の
融点、IR及び1H−NMRの測定結果は次の通りであった。Melting point: 50.6-52.8 ° C IR: 3304, 2924, 2856, 1734, 1616, 1470, 1176, 110
8,1060,720cm -1 1 H-NMR (δ , CDCl 3): 0.82~0.95 (m, 6H), 1.13~1.74 (m, 62H), 1.96~
2.13 (m, 4H), 2.29 (t, J = 7.5Hz, 2H), 2.39 (bt, J =
7.6Hz, 2H), 2.77 (bt, J = 5.7Hz, 2H), 3.22 to 4.21 (m,
13H), 4.05 (t, J = 6.71Hz, 2H), 5.23 to 5.48 (m, 4H) Example 11 N- (2-hydroxy-3-hexadecyloxypropyl) -N-2-hydroxyethyl-15- (9Z, 12Z-octadecadienoyloxy) pentadecane amide [in the general formula (I), R 1 ═C 16 H 33 − and Synthesis of amide derivative] (I-Ch): The reaction was performed in the same manner as in Example 10 except that methyl 15-hydroxypentadecanoate was used instead of methyl 12-hydroxydodecanoate in Example 10. The target compound (I-Ch) was obtained (yield 42.3%). The melting point, IR and 1 H-NMR measurement results of the obtained compound were as follows.
融点:64.2〜65.7℃ IR:3312、2924、2856、1734、1618、1466、1440、118
6、1110、1060、722cm-1 1 H−NMR(δ,CDCl3): 0.82〜0.97(m,6H)、1.15〜1.63(m,58H)、1.96〜
2.14(m,4H)、2.29(t,J=7.5Hz,2H)、2.39(bt,J=
7.6Hz,2H)、2.77(bt,J=5.7Hz,2H)、3.21〜4.20(m,
13H)、4.05(t,J=6.7Hz,2H)、5.23〜5.48(m,4H) 実施例12 下記第1表に示す本発明のアミド誘導体10%及びスク
ワラン90%からなる本発明の皮膚外用剤をそれぞれ製造
し、これらの皮膚外用剤について、下記の試験方法によ
り経表皮水分蒸散量及び経皮吸収量を評価した。また、
比較としてスクワランのみからなる皮膚外用剤(比較
品)についても同様の試験を行った。その結果を下記第
1表に示す。Melting point: 64.2-65.7 ° C IR: 3312, 2924, 2856, 1734, 1618, 1466, 1440, 118
6,1110,1060,722cm -1 1 H-NMR (δ , CDCl 3): 0.82~0.97 (m, 6H), 1.15~1.63 (m, 58H), 1.96~
2.14 (m, 4H), 2.29 (t, J = 7.5Hz, 2H), 2.39 (bt, J =
7.6Hz, 2H), 2.77 (bt, J = 5.7Hz, 2H), 3.21 ~ 4.20 (m,
13H), 4.05 (t, J = 6.7Hz, 2H), 5.23 to 5.48 (m, 4H) Example 12 External skin application of the present invention consisting of 10% of the amide derivative of the present invention shown in Table 1 below and 90% of squalane. Each of these preparations was manufactured, and the transepidermal water loss and percutaneous absorption of these external preparations for skin were evaluated by the following test methods. Also,
As a comparison, the same test was performed on a skin external preparation (comparative product) consisting of squalane alone. The results are shown in Table 1 below.
(試験方法) 必須脂肪酸を含まない飼料のみでウィスター(Wiste
r)系雄性ラットを飼育し、必須脂肪酸欠乏症の症状が
現れたラットに対し、剃毛した背部皮膚に皮膚外用剤を
1日1回3週間塗布する。3週間の塗布が終了した翌日
に次の項目について試験を行った。(Test method) Wistar with only feed that does not contain essential fatty acids
r) male rats are bred, and external skin preparations are applied to the shaved back skin once a day for 3 weeks to rats showing symptoms of essential fatty acid deficiency. The test was conducted on the following items the day after the application for 3 weeks was completed.
尚、皮膚外用剤それぞれについてラット3匹ずつを試
験に供した。In addition, three rats were subjected to the test for each external preparation for skin.
(1)経表皮水分蒸散量 37℃の温水でラットの背部皮膚を洗浄後、温度20℃及
び湿度45%の部屋で1時間安静な状態においた後、表皮
からの水分蒸散量をエバポリメーターにて測定した。こ
の水分蒸散量の値が大きいほど角層のバリアー機能が低
下しており、肌あれが生じていることを示す。(1) Transepidermal water loss After washing the rat's back skin with warm water at 37 ℃, leave it in a room at a temperature of 20 ℃ and a humidity of 45% for 1 hour, and then measure the water loss from the epidermis with an evaporation meter. It was measured at. The larger the value of this water evaporation amount, the lower the barrier function of the stratum corneum, indicating that the skin is roughened.
正常なバリアー機能が維持されている場合、この値は
10以下となるが、バリアー機能が障害を受けた必須脂肪
酸欠乏症のラットでは35以上となる。測定値は平均値±
標準偏差で示した。If the normal barrier function is maintained, this value is
It is 10 or less, but 35 or more in essential fatty acid deficient rats with impaired barrier function. Measured values are mean ±
The standard deviation is shown.
(2)経皮吸収量 37℃の温水でラットの背部皮膚を洗浄後、該皮膚を切
り取り、経皮吸収チャンバーに表皮側を上にしてはさみ
込む。下部受器にはリン酸緩衝平衡塩類溶液を満たし、
表皮側容器には37KBqの14C−サリチル酸を含む溶剤1ml
を入れる。2時間後に下部受器中に浸透した14C−サリ
チル酸量を測定する。正常なバリアー機能が維持されて
いる場合、2時間ではほとんど浸透せず、バリアー機能
の障害が大きいほどこの値は大きくなる。測定値は平均
値±標準偏差で示した。(2) Percutaneous absorption amount After washing the back skin of rats with warm water at 37 ° C, the skin is cut off and inserted into the transdermal absorption chamber with the epidermis side facing up. Fill the lower receiver with phosphate buffered balanced salt solution,
1 ml of solvent containing 37 KBq of 14 C-salicylic acid in the epidermal container
Insert After 2 hours, the amount of 14 C-salicylic acid that has penetrated into the lower receiver is measured. When the normal barrier function is maintained, it hardly penetrates in 2 hours, and the larger the impaired barrier function, the larger the value. The measured values are shown as the average value ± standard deviation.
実施例13 本発明のアミド誘導体を用いて、下記第2表に示す組
成の本発明の皮膚外用剤(乳化化粧料)をそれぞれ製造
し、その肌あれ改善効果を下記の試験方法により評価し
た。また、比較として本発明のアミド誘導体を含まない
皮膚外用剤(比較品)についても同様の試験を行った。
その結果を下記第3表に示す。 Example 13 Using the amide derivative of the present invention, a skin external preparation (emulsified cosmetic) of the present invention having the composition shown in Table 2 below was produced, and its skin roughening improving effect was evaluated by the following test methods. Further, for comparison, the same test was performed on an external preparation for skin (comparative product) containing no amide derivative of the present invention.
The results are shown in Table 3 below.
(試験方法) 冬期に頬部に肌あれを起こしている20〜40才の女性10
名を被験者とし、左右の頬に異なる皮膚外用材を1日1
回3週間塗布する。3週間の塗布が終了した翌日に次の
項目について試験を行った。(Test method) Women aged 20 to 40 who have rough skin on the cheeks in winter 10
First name is test subject, and different skin external materials on left and right cheeks 1 a day
Apply 3 times a week. The test was conducted on the following items the day after the application for 3 weeks was completed.
(1)経表皮水分蒸散量 37℃の温水で洗顔後、温度20℃及び湿度45%の部屋で
30分間安静にした後、表皮からの水分蒸散量をエバポリ
メーターにて測定した。この水分蒸散量の値が大きいほ
ど角層のバリアー機能が低下しており、肌あれが生じて
いることを示す。この値が40を超えるとひどい肌あれで
あり、肌あれがほとんど認められない場合は10以下とな
る。測定値は平均値±標準偏差で示した。(1) Transepidermal water loss After washing the face with warm water at 37 ℃, in a room at a temperature of 20 ℃ and a humidity of 45%
After resting for 30 minutes, the amount of water evaporated from the epidermis was measured with an evaporation meter. The larger the value of this water evaporation amount, the lower the barrier function of the stratum corneum, indicating that the skin is roughened. When this value exceeds 40, the skin is severely roughened, and when it is hardly observed, it becomes 10 or less. The measured values are shown as the average value ± standard deviation.
(2)肌あれスコア 肌あれを肉眼で観察し、下記基準に測定した。スコア
は平均値±標準偏差で示した。(2) Rough skin score The rough skin was observed with the naked eye and measured according to the following criteria. Scores were shown as mean ± standard deviation.
スコア 肌あれ判定 0 肌あれを認めない 1 かすかに肌あれを認める 2 肌あれを認める 3 ややひどい肌あれを認める 4 ひどい肌あれを認める 〔発明の効果〕 本発明のアミド誘導体を含有する皮膚外用材は、角層
のバリアー機能を本質的に改善できる効果を有するもの
で、皮膚に適用することにより、炎症や肌あれ等を起こ
し難くすることができる。Score Rough skin judgment 0 No rough skin is recognized 1 Slight rough skin is recognized 2 Rough skin is recognized 3 Slightly rough skin is recognized 4 Severe rough skin is recognized [Effects of the Invention] The external preparation for skin containing the amide derivative of the present invention has the effect of essentially improving the barrier function of the stratum corneum, and when applied to the skin, it is less likely to cause inflammation, rough skin, etc. can do.
Claims (2)
体。 (式中、R1は炭素数10〜40の直鎖若しくは分岐鎖の飽和
若しくは不飽和の炭化水素基を示し、R2は炭素数3〜39
の直鎖若しくは分岐鎖の炭化水素基を示し、R3は水素原
子又は炭素数10〜40の直鎖若しくは分岐鎖の飽和若しく
は不飽和の炭化水素基若しくはアシル基を示す。)1. An amide derivative represented by the following general formula (I). (In the formula, R 1 represents a linear or branched saturated or unsaturated hydrocarbon group having 10 to 40 carbon atoms, and R 2 represents 3 to 39 carbon atoms.
Is a straight chain or branched chain hydrocarbon group, and R 3 is a hydrogen atom or a straight chain or branched chain saturated or unsaturated hydrocarbon group having 10 to 40 carbon atoms or an acyl group. )
体を含有する皮膚外用剤。 (式中、R1は炭素数10〜40の直鎖若しくは分岐鎖の飽和
若しくは不飽和の炭化水素基を示し、R2は炭素数3〜39
の直鎖若しくは分岐鎖の炭化水素基を示し、R3は水素原
子又は炭素数10〜40の直鎖若しくは分岐鎖の飽和若しく
は不飽和の炭化水素基若しくはアシル基を示す。)2. A skin external preparation containing an amide derivative represented by the following general formula (I). (In the formula, R 1 represents a linear or branched saturated or unsaturated hydrocarbon group having 10 to 40 carbon atoms, and R 2 represents 3 to 39 carbon atoms.
Is a straight chain or branched chain hydrocarbon group, and R 3 is a hydrogen atom or a straight chain or branched chain saturated or unsaturated hydrocarbon group having 10 to 40 carbon atoms or an acyl group. )
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP24684790A JP2686172B2 (en) | 1990-09-17 | 1990-09-17 | Amide derivative and external preparation for skin containing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP24684790A JP2686172B2 (en) | 1990-09-17 | 1990-09-17 | Amide derivative and external preparation for skin containing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH04128256A JPH04128256A (en) | 1992-04-28 |
| JP2686172B2 true JP2686172B2 (en) | 1997-12-08 |
Family
ID=17154599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP24684790A Expired - Fee Related JP2686172B2 (en) | 1990-09-17 | 1990-09-17 | Amide derivative and external preparation for skin containing the same |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2686172B2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60043187D1 (en) | 1999-04-08 | 2009-12-03 | Kao Corp | COMPOSITIONS FOR EXTERNAL USAGE |
| JP5715559B2 (en) * | 2008-05-14 | 2015-05-07 | カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ | 9,10,12-Triacyloxyoctadecanoic acid alkyl ester and 9,10,12-triacyloxyoctadecanoic acid alkyl ester-rich fatty acid alkyl ester mixture and process for producing them |
-
1990
- 1990-09-17 JP JP24684790A patent/JP2686172B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH04128256A (en) | 1992-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5175321A (en) | Amide derivatives and dermatologic preparations containing the same | |
| US7351716B2 (en) | Dermatological preparations | |
| JPH05255217A (en) | P-menthane derivative and chilling agent containing the derivative | |
| JPH0517399A (en) | Ester derivative and cosmetics containing the same | |
| JP2946145B2 (en) | Cosmetics | |
| EP0450527A2 (en) | N-Tris(hydroxymethyl)methylfatty acid amides and cosmetic compositions containing same | |
| JPH0142934B2 (en) | ||
| JP2686172B2 (en) | Amide derivative and external preparation for skin containing the same | |
| JP4070357B2 (en) | Skin preparation | |
| US5221757A (en) | Amide derivatives and dermatologic preparations containing the same | |
| JPH072698B2 (en) | Amide derivative and external preparation for skin containing the same | |
| JP3073813B2 (en) | Cosmetics | |
| JP4112741B2 (en) | Moisturizer | |
| US5801258A (en) | Amide derivatives and dermatologic preparations containing the same | |
| JP2551471B2 (en) | Glyceryl ether derivative and skin external preparation containing the same | |
| JPH0316172B2 (en) | ||
| JPH05255186A (en) | 3-substituted-p-menthane derivative and cold-sensation agent containing the same derivative | |
| JP3833724B2 (en) | Wrinkle improver | |
| JP3271828B2 (en) | Water-in-oil emulsion cosmetics | |
| JP3769056B2 (en) | Amine derivative and skin external preparation containing the same | |
| JPH02306949A (en) | Amide derivative and external preparation for skin containing the same | |
| JPH06157507A (en) | Amide derivative and skin external preparation containing the same | |
| JP2704759B2 (en) | Glyceryl ether derivative and external preparation for skin containing the same | |
| JP3788633B2 (en) | Phosphoric acid triester and cosmetics and external preparations containing the same | |
| JPH1135443A (en) | Moisturizer, skin-roughening improving agent and skin lotion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080815 Year of fee payment: 11 |
|
| LAPS | Cancellation because of no payment of annual fees |